Order Article Reprints

Sicuranza A, Breccia M, Iuliano F, Gugliotta G, Castagnetti F, Lunghi M, Patriarca A, Intermesoli T, Luciano L, Russo Rossi A, et al. Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. Vaccines. 2025; 13(4):419. https://doi.org/10.3390/vaccines13040419

Sicuranza, Anna, Massimo Breccia, Francesco Iuliano, Gabriele Gugliotta, Fausto Castagnetti, Monia Lunghi, Andrea Patriarca, Tamara Intermesoli, Luigiana Luciano, Antonella Russo Rossi, and et al. 2025. "Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies" Vaccines 13, no. 4: 419. https://doi.org/10.3390/vaccines13040419

Sicuranza, A., Breccia, M., Iuliano, F., Gugliotta, G., Castagnetti, F., Lunghi, M., Patriarca, A., Intermesoli, T., Luciano, L., Russo Rossi, A., Rege Cambrin, G., Vucinic, V., Malagola, M., Malato, A., Abruzzese, E., D’Adda, M., Galimberti, S., Defina, M., Sammartano, V., ... Bocchia, M. (2025). Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. Vaccines, 13(4), 419. https://doi.org/10.3390/vaccines13040419